Treatment of small intestine bacterial overgrowth and related symptoms by rifaximin

Michele Di Stefano, Gino Roberto Corazza

Research output: Contribution to journalArticlepeer-review


The treatment of small intestine bacterial overgrowth should address different aims: the removal of the predisposing condition, guarantee of adequate nutritional support to reintegrate both caloric and vitamin requirements and, obviously, suppression of the contaminating bacterial flora, which represents the major goal. The polymicrobic nature of contaminating flora suggests the administration of wide-spectrum antibiotics, but until now there has been no conclusive information on the most effective therapeutic approach. In this paper, the efficacy of the different therapeutic approaches used is reviewed.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
Issue numberSUPPL. 1
Publication statusPublished - 2005


  • Nonabsorbable antibiotics
  • Rifaximin
  • Small intestine bacterial overgrowth
  • Therapy

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Treatment of small intestine bacterial overgrowth and related symptoms by rifaximin'. Together they form a unique fingerprint.

Cite this